Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

June 12, 2020
Case Report
Open Access


AACE Clinical Case Reports
Sara BedroseSonali N Thosani
July 23, 2020
Case Report
Open Access

Meningitis as the initial manifestation of systemic lupus erythematosus

Nada Al MahmeedAhmad Rakad Nusair
June 18, 2020
Open Access

Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980-2016

Clinical Epidemiology
Dennis Lund HansenHenrik Frederiksen
July 8, 2020
Open Access

Beat the heat: Culex quinquefasciatus regulates its body temperature during blood-feeding

BioRxiv : the Preprint Server for Biology
June 18, 2020

Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia

Annals of Hematology
Paul R J Ames, Susan Jeffrey
June 10, 2020

Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease

Journal of Nephrology
Adi Nitzan-LuquesOded Volovelsky
June 9, 2020

Identification of the target molecule of autoantibodies in acquired autoimmune hemolytic anemia

[Rinshō ketsueki] The Japanese journal of clinical hematology
Shinichiro Kawamoto
July 4, 2020

Non-immune haemolytic anaemia in a patient with acute hepatitis B

Medicina clínica
Antonio Amo-LozanoJoaquín Portilla
July 11, 2020

Autoimmune Hemolytic Anemia as Presenting Manifestation of Multiple Myeloma

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
Rahul Naithani, Nitin Dayal
July 2, 2020

Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan

International Journal of Hematology
Toyomi KamesakiYuzuru Kanakura
July 24, 2020
Case Report
Open Access

Ceftriaxone-Induced Immune Hemolytic Anemia

Anil SinghSubhankar Samal
July 14, 2020
Open Access

Treatment with rivaroxaban and monitoring of coagulation profiles in two dogs with venous thromboembolism

The Journal of Veterinary Medical Science
Mona UchidaHajime Tsujimoto
June 21, 2020

Drug-induced immune hemolytic anemia investigation: comparison between tube test and microcolumn agglutination (gel test) for the detection of drug-dependent antibodies in the presence of soluble drug.

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
Tan Ngoc NguyenJulia Moh Klaren
June 17, 2020

Ibrutinib treatment for 2 cases of relapsed/refractory autoimmune hemolytic anemia: a pilot study

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
L W FangJ Shi

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

© 2020 Meta ULC. All rights reserved